appendicitis
Appendicitis refers to inflammatory changes in the appendix due to various factors. It is a common disease, and its prognosis depends on whether it is diagnosed and treated in time. With early diagnosis and treatment, most patients can recover in a short period of time, and the mortality rate is extremely low (0.1%-0.2%); if the diagnosis and treatment are delayed, it can cause serious complications and even death. Appendicitis is a common disease. Clinically, there are often symptoms such as right lower abdominal pain, fever, vomiting, and neutrophilia. Appendicitis is an inflammation of the appendix, the most common abdominal surgical disease.
-
Site of disease:
appendix -
Infectious :
Not contagious -
Frequent population:
Young people -
Related symptoms:
Stomach ache right lower abdominal pain nausea and vomiting loss of appetite nausea -
Concurrent disease:
Related Drugs
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
Reyoung Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection (4:1)
Indication: This product is suitable for the following moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis; 2. Uncomplicated and complicated skin and soft tissue infections, including cellulitis, skin abscess, ischemic or diabetic foot infection; 3. Postpartum endometritis.
Manufacturer:
Hainan General Sanyang Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: Infections caused by sensitive bacteria, such as acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess, bronchiectasis or asthma infection; acute pyelonephritis, acute exacerbation of chronic pyelonephritis, acute cystitis, acute prostatitis, complicated urinary tract infection; appendicitis, peritonitis, intra-abdominal abscess; wound infection, cellulitis, skin abscess, ischemic necrosis and infection of diabetic foot; pelvic infection, endometritis; bone and joint infection, mixed infection with multiple bacteria, bacterial sepsis, toxemia, sepsis.
Manufacturer:
Hainan General Sanyang Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for the following moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to tazobactam/piperacillin: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovale, Bacteroides thetaiotaomicron). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or local bacterial infections caused by sensitive bacteria.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (accompanied by perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovale, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (accompanied by perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovale, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or local bacterial infections caused by sensitive bacteria.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam: 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or local bacterial infections caused by sensitive bacteria.
Related Ingredients